Asia Pacific's Leading MedTech Conference
Asia Pacific's Leading MedTech Conference
PROGRAMME
5 December - Plenary Venue: Hall 406
0900 – 0930 hrs
Registration, Networking & Innovation Exhibition Visit
0930 – 1010 hrs
Welcome to MedTech Forum 2023: Innovation Unleashing Human Potential
APACMed Board Chairman, John Collings, will officially kick off the forum providing an overview of the Forum, elaborate on its theme, and introduce the concept of the three E’s. Through insightful reflections, he will share a roadmap for the forum, offering valuable perspectives on advancing innovation in the healthcare sector.
Bringing in the Patient Perspective
In her role as President of the Brain Tumour Society (Singapore), Melissa brings patient representation to this session, sharing a heartfelt and sincere narrative of the potential, challenges, and even pitfalls of medical innovation. It’s a compelling story that sheds light on the profound influence of MedTech innovation on patients’ lives.
John Collings
Chairman, APACMed
President, Stryker, Asia Pacific
Melissa Lim
President
Brain Tumour Society (Singapore) Limited
1010 – 1040 hrs
Keynote Session 1
Roche: A 127-year Journey of Innovation
As the global CEO of a MedTech giant, Thomas will elucidate the significance of innovation and the three E’s in the MedTech industry, also providing valuable insights into Roche’s unique innovation strategy, its evolution and implications for patients and talent.
Thomas Schinecker
Chief Executive Officer
Roche Group
Fireside Chat: Lance Little in conversation with Harjit Gill
Sharing candid insights into the significance of innovation in MedTech Industry, Lance reflects on Roche’s innovation strategy, including both its triumphs and tribulations. Both speakers jointly highlight the critical role that industry plays in shepherding medical innovation.
Lance Little
Head of Region
Roche Diagnostics Asia Pacific
Harjit Gill
CEO
APACMed
1040 – 1200 hrs
Keynote Session 2
A Human's Guide to the Future, and the Role of MedTech Innovation
Step into the forefront of medical innovation with Dr Jordan in this enlightening session. Discover the vast potential of medical innovation as he provides a glimpse into the future with forward-looking predictions and how we can unlock innovation’s potential by upgrading human capital.
Dr. Jordan Nguyen
Author
A Human's Guide to the Future
Fireside Chat: Dr. Jordan Nguyen in conversation with Chris Hardesty
This fireside chat delves into the implications of Innovation for the MedTech industry. A senior executive shares insights on their company’s balance between innovation and real-world adoption, aligning with the three E’s model. The subsequent dialogue between Jordan and the industry leader explores whether we’re pushing medical innovation too far in the Asia Pacific, and discusses practical approaches to aligning human skills with innovation, identifying key opportunities and risks.
Chris Hardesty
Strategic Advisor
APACMed
1200 – 1230 hrs
Keynote Session 3
Terumo: An Asian MedTech Becoming a Global Leader
Explore the Asian MedTech perspective with Terumo, a unique multinational rooted in the region. Sato San will take us on a journey through Terumo’s evolution, charting its progression from its origins in Asia to its current global stature, uncover essential elements that contributed to success in the Asian context, emphasizing the pivotal role of talent.
Shinjiro Sato
Global Group President & CEO
Terumo Corporation
Sam Karita
Managing Director and Senior Partner
Boston Consulting Group
Session Moderator
1230 – 1400 hrs
Networking Lunch
1400 – 1505 hrs
Panel Discussion
MedTech Innovation: Fulfilling the Promise for Patients
Innovation is at the heart of MedTech, exploring new frontiers and revolutionizing the landscape of patient care.
Our Panel session on “Medical Innovation: Fulfilling Our Promise” will explore the complexities surrounding medical innovation in this thought-provoking panel discussion. Industry leaders will dive into the transformative power of innovation, the ecosystem’s readiness to embrace MedTech innovations and its impact on healthcare workforce, patients and healthcare industry as a whole.
Koh Hau-Tek
Chief Medical Officer
GWS Medical
Dr. Hatim Abdulhussein
National Clinical Lead - AI and Digital Workforce, UK
NHS
Farhana Nakhooda
General Manager & Senior Vice President, Asia Pacific Health Catalyst
Heather Renton
Founder and former CEO
Syndromes Without A Name (SWAN) Australia
Saurabh Rajadhyax
Sr. Vice President Clinical Operations, Asia Pacific
bioMérieux
Feng Dong
Vice President, Asia Region-Led Markets for Global Regions
Medtronic
Vy Tran
Asia Pacific Japan President
Siemens Healthineers
Anastasia Miros
Director, Healthcare and Life Sciences, Asia Pacific
KPMG
Session Moderator
1505 – 1600 hrs
Panel Discussion
Empowering Patients: Embracing the Challenge of Innovation and Human Potential
Embark on the journey of embracing innovation and human potential in this dynamic panel session.
Join the MedTech industry leaders addressing the challenges of embracing innovation, its impact on human potential, delving into what innovation signifies for each participating organization and industry’s pivotal role in advancing innovation.
Pavan Mocherla
President, Greater Asia
Becton Dickinson
Stephen Morse
Senior Vice President & President, Asia Pacific
Boston Scientific
Joanna Yao
Vice President, Asia
Baxter International
James Chiang
VP / General Manager, Asia
embecta
Vikram Kapur
Senior Partner, Head of APAC Healthcare & Life Sciences
Bain & Company
Session Moderator
1600 – 1700 hrs
MedTech Innovator Awards
MedTech Innovator Awards
Commencing with an overview of MedTech Innovator Awards, this session will feature compelling pitches from top-selected start-ups. The session will also witness an enlightening dialogue with industry leaders, sharing their cutting-edge product/services, providing valuable insights into the collaborative dynamics shaping the MedTech landscape.
Marc Radatt
CEO Asia-Pacific
Olympus
Brian Benson
VP, Strategic Alliances
MedTech Innovator
Biten Kathrani
Head of R&D, APJ region and Global Special Contact Lens Research, Vision
Johnson & Johnson MedTech
Praneet Mehrotra
President APAC
Teleflex
Christian Kapischke
SVP Operations
BBraun Medical
Vy Tran
Asia Pacific Japan President
Siemens Healthineers
1800 hrs onwards
Social Reception & Networking at SKAI Loft, Swissôtel The Stamford, Singapore(Pre-Registration mandatory)
6 December - Innovation Day and Expert Summits
Expert Summits
0830 – 1115 hrs
Hall 406 (Level 4)
Public Policy & Market Access Summit:
Strengthening the Ecosystem for Evidence-based Policymaking
0830 – 0835 hrs
Welcome and Introduction of GAMA Committee
Glenda Teng
Director, Government Affairs and Market Access
APACMed
0835 – 0840 hrs
Opening Remarks
Shakilla Shahjihan
Divisional Vice President Government Affairs, Asia Pacific & Japan
Abbott Laboratories
0840 – 0850 hrs
Presentation
APACMed ESG Dashboard & 2024 Plans
Benish Aslam
Manager, Government Affairs and Market Access
APACMed
0850 – 0900 hrs
Presentation
Why ESG matters for MedTech in APAC
Vikram Kapur
Senior Partner, APAC Healthcare and Life Sciences
Bain & Co
0900 – 0935 hrs
Panel Discussion
ESG for MedTech: What Lies Ahead? Perspectives from across the globe
Sigrid Linher
Sustainability & Environment Director
MedTech Europe
Pravin Siriwardena
Policy Manager
Medical Technology Association of Australia (MTAA)
Gwyneth Fries
Expert Senior Manager, Sustainability
Bain & Co
Session Moderator
0935 – 0950 hrs
Presentation
Government Collaboration for Creating a New Service Fee for IVD in South Korea
Saeim Teresa Chun
Market Access, and Public & Government Affairs Senior Manager
bioMérieux
0950 – 1000 hrs
Fireside Chat
Value-Based Pricing for MedTech: A Collaborative Way Ahead for Singapore
Anthony Morton-Small
Managing Director
Vista Health Pte Ltd
Ong Su Fen
Manager, Government Affairs and Market Access
APACMed
1000 – 1030 hrs
Panel Discussion
Evidence-driven Decision Making for Healthcare in APAC
Markus Siebert
Senior Director Health Economics & Reimbursement, OUS
Abbott
A/Prof Tam C. Nguyen
Deputy Director of Research,
St Vincent’s Hospital Melbourne;
Associate Professor,
Melbourne Medical School
Adrien Gras
Head of Market Access & HEOR, APAC
IPSOS
Session Moderator
1030 – 1040 hrs
Presentation
Volume to Value: Roadmap for Promoting R&D in India's Medical Device Sector
Adip Puri
Country Lead, India
APACMed
1040 – 1110 hrs
Panel Discussion
Promoting Quality Innovation in the Asia-Pacific Region
Makoto Kawai
Chair of Public Affairs Committee, Orthopaedics Committee, and Strategy Management Office, AMDD
Chair of Healthcare Committee, and Vice-Chair of Govt Affairs Committee, ACCJ (American Chamber of Commerce Japan)
Jeff Weisel
Managing Director, APAC
Avalere Health
Session Moderator
1110 – 1115 hrs
Closing Remarks
Dr Alice Chu
Senior Director, Market Access and Medical Affairs, APAC
Glaukos
0900 – 1100 hrs
Room 325 (Level 3)
China Summit – Morning Session
MedTech Collaboration: ASEAN-China Opportunities (ASEAN Focus)
0900 – 0915 hrs
Opening Remarks
Alicia Chang
China Lead
APACMed
John Eng
VP, Health Practice
EDB
0915 – 0935 hrs
Presentation
ASEAN MedTech: Trend and Analysis
Frank Mei
Head of Enterprise Risk Services KPMG Asia Pacific
China Life Science Advisory Partner
KPMG China
0935 – 1015 hrs
Presentation
ASEAN Regulatory Policy Updates
Salbiah Yaakop
Director of Policy and Strategic Planning
Malaysia Medical Device Authority
Helsy Pahlemy
Head of Team for Supervision and Certification of Medical Devices Distribution Facilities
Indonesia MoH
1015 – 1055 hrs
Panel Discussion
Pathway into ASEAN-strategies and approaches
May Ng
Group CEO
ARQon
Dr. Koh Hau-Tek
Chief Medical Officer
GWS Medika
Yizhi Lin
Chairman and CEO
Ustar
Yeo Su Ling
Director, Venture Creation and Growth, Innovation & Enterprise Group
A*STAR
Dr. Abhishek Bhatia
Director
The Voices Project Asia
Jon Bastow
Health System Innovator
Independent
Dr. Ming Xu
Chair and Research Professor, Global Health Department, School of Public Health;
Associate Dean, Institute for Global Health and Development
Peking University
Session Moderator
1055 – 1100 hrs
Closing Remarks
1230 – 1400 hrs
Room 325 (Level 3)
China Summit – Afternoon Session:
Forging Synergies: Pathways into China (China Focus)
1230 – 1240 hrs
Opening Remarks
Alicia Chang
China Lead
APACMed
1240 – 1305 hrs
Presentation
New Trends of Out-of-hospital Care and Demands for Innovative Medical Technologies in China
Prof. Lan Yao
Professor, Dean, School of Medicine and Health Management Huazhong University of Science and Technology; Executive Director, Research Institute of NHSA
Huazhong University of Science and Technology
Fireside Chat
The Formulation of Out-of-hospital Care Models
Prof. Lan Yao
Professor, Dean, School of Medicine and Health Management Huazhong University of Science and Technology; Executive Director, Research Institute of NHSA
Huazhong University of Science and Technology
Yi Feng Lai
Assistant Director
MOH Office for Healthcare Transformation, Singapore
Grace Wang
Partner
L.E.K. China
Session Moderator
1305 – 1330 hrs
Presentation followed by Q&A
DRG-based Market Access of the Innovative Medical Technologies
Dr. Pei Li
Researcher, HUST Sub-Base
National Institute of Healthcare Security
Yvonne Lee
Principal and Head of Real-World Evidence, Asia Pacific
IQVIA
Session Moderator
1330 – 1355 hrs
Presentation followed by Q&A
Regulatory Green Pathways into China
Yawen Wang
Reviewer
Division of Clinical and Biostatistics I, Center for Medical Device Evaluation (CMDE), NMPA
Ruslan Tulenov
Global Press Officer; Deputy Director for Investment Promotion Department
Hainan International Economic Development Bureau
Jason Guo
APAC Director, Regulatory Affairs, Quality And Compliance
Abbott
Session Moderator
1355 – 1400 hrs
Closing Remarks
1200 – 1500 hrs
Hall 406 (Level 4)
Regulatory Affairs Summit:
APAC AI/ML Regulations & Regulatory Convergence
1200 – 1205 hrs
Opening Remarks
Cindy Pelou
Regulatory Affairs Manager
APACMed
1205 – 1220 hrs
Key Regulatory Trends
Davina R. Marano, JD, MS, CIB.
Senior Regulatory Counsel, International Affairs
US Food and Drug Administration, IMDRF
1220 – 1235 hrs
Presentation
MOH Journey on Cybersecurity Labelling Scheme for Medical Devices
Raymond Chua
Deputy Director-General of Health (Health Regulation), Assistant Commissioner (Cybersecurity – Healthcare)
Ministry of Health, Singapore
1235 – 1250 hrs
Presentation
AI/ML Regulations
Mansoor Mukadam
Principal, APAC
Clarivate Consulting
1250 – 1330 hrs
Panel Discussion
AI/ML Regulations and Emerging Technologies
Johan Ordish
Head of Digital Health and Innovation Policy
Roche Diagnostics
Lin Anle
Senior Regulatory Specialist,
Digital Health Branch,
Medical Devices Cluster,
Health Products Regulation Group
Health Sciences Authority, Singapore
Dr. Madoka Murakami
Principal Reviewer
Pharmaceuticals and Medical Device Agency, Japan
Tracey Duffy
First Assistant Secretary
Therapeutics Goods Administration, Australia
Byung-gwan Kim
Assistant Director
Ministry of Food and Drug Safety, Korea
Hong Liang
Reviewer
National Medical Products Administration, China
Mansoor Mukadam
Principal, APAC
Clarivate Consulting
Session Moderator
1330 – 1350 hrs
Presentation
Introduction to Regulatory Harmonisation and Convergence
Dr Samvel Azatyan
Team Lead, Regulatory Convergence and Networks
World Health Organisation
Yasha Huang
Head Regulatory Policy Asia Pacific
Global Regulatory Policy & Intelligence
Roche Diagnostics
1350 – 1430 hrs
Panel Discussion
Regulatory Harmonisation and Convergence
Low Lai Peng
Deputy Director of Therapeutics Devices
Health Sciences Authority, Singapore
Dr Muralitharan
CEO
Medical Device Authority, Malaysia
Bach Minh Hung
IMDA Officer
Infrastructure and Medical Device Adminisration (IMDA) - Ministry of Health of Vietnam
Vo Duong Phan Nghia
IMDA Officer
Infrastructure and Medical Device Adminisration (IMDA) - Ministry of Health of Vietnam
Tracey Duffy
First Assistant Secretary
Therapeutics Goods Administration, Australia
Dr. Madoka Murakami
Principal Reviewer
Pharmaceuticals and Medical Device Agency, Japan
Miang Tanakasemsub
Head of Regulatory Affairs, Asia Pacific, Vision
Johnson & Johnson MedTech
Session Moderator
1430 – 1500 hrs
Panel Discussion
RA Committee Updates and Events
Miang Tanakasemsub
Head of Regulatory Affairs, Asia Pacific, Vision
Johnson & Johnson MedTech
James Chan
APAC Regulatory Affairs Director
Varian Medical Systems (a Siemens Healthineers Company)
Yasha Huang
Head Regulatory Policy Asia Pacific
Global Regulatory Policy & Intelligence
Roche Diagnostics
Jason Guo
APAC Director, Regulatory Affairs, Quality And Compliance
Abbott
Cindy Pelou
Regulatory Affairs Manager
APACMed
Session Moderator
1430 – 1730 hrs
Room 325 (Level 3)
In-Vitro Diagnostics Summit:
Addressing Access Barriers for Diagnostics
1430 – 1450 hrs
Presentation
Opening Remarks and Addressing Access Barriers for Diagnostics: Overview of APACMed's Engagement
Benish Aslam
Manager, Diagnostics Projects
APACMed
1450 – 1500 hr
Fireside Chat
Addressing Access Barriers for Diagnostics
Anh Bourcet
Strategic Advisor
APACMed
Nordin Charafi
Director Market Access, Asia Middle East and Africa
Illumina
1500 – 1510 hrs
Virtual Recording
World Health Assembly Resolution on Strengthening Diagnostic Capacity
Dr. Michael Wilson
Deputy Chair, The Lancet Commission on Diagnostics
Professor and Vice Chair, Dept of Pathology, University of Colorado
Director, Dept of Pathology & Lab Services Denver Health
1510 – 1520 hrs
Virtual Recording
World Health Assembly Resolution on Strengthening Diagnostic Capacity: What does it mean for APAC? - An Interactive Discussion
Dr. Bill Rodriguez
CEO
FIND
1520 – 1615 hrs
Panel Discussion
Realising The Full Value of Diagnostics in Bringing Health for All: A Collaborative Approach
Ho Yuan Lu
VP, Outreach and Talent
Diagnostics Development Hub
Dr Joanne Yoong
Founder
Research For Impact
Dr. Ming Xu
Chair and Research Professor, Global Health Department, School of Public Health; Associate Dean, Institute for Global Health and Development
Peking University
Arika Garg
Associate Director, Diagnostics
Clinton Health Access Initiative
William Brown
Senior Director
Vista Health
Session Moderator
1615 – 1625 hrs
Presentation
Patient Perspective on the Value of Precision Medicine and Importance of Next-Generation Sequencing Technologies
Richard Vines
Director
Rare Cancers Australia
1625 – 1720 hrs
Panel Discussion
Setting foundational standards to unlock the Value for Next-Generation Sequencing Technologies
Dr. Herbert H. Loong
Associate Professor (Clinical), Department of Clinical Oncology
The Chinese University of Hong Kong
Dr. Karthik G M
Associate Director, Regulatory Affairs
Asia, Middle East and Africa (AMEA)
Guardant Health AMEA
Richard Vines
Director
Rare Cancers Australia
Prof Tony Lim Kiat Hon
Senior Consultant and Chairman, Division of Pathology
Singapore General Hospital;
Academic Chair, Pathology Academic Clinical Programme
SingHealth Duke-NUS
William Brown
Senior Director
Vista Health
Session Moderator
1720 – 1730 hrs
Closing Remarks
Benish Aslam
Manager, Diagnostics Projects
APACMed
1500 – 1800 hrs
Hall 406 (Level 4)
Digital Health Summit:
Enter the Next Healthcare Evolution — Digital!
1500 – 1510 hrs
Opening Remarks
Anirudh Sen
Director, Digital Health
APACMed
1510 – 1540 hrs
Fireside Chat: EMPOWER Patients
The Digital Native: Leading the Consumerization of Healthcare
Yoann Sapanel
Head of Health Innovation
WisDM, the Institute for Digital Medicine at the NUS School of Medicine
Heather Renton
Founder and former CEO
Syndromes Without a Name (SWAN) Australia
Yong Yih Ming
Chief Operating OfficerIHH Healthcare Singapore;
Chief Executive Officer
Mount Elizabeth Hospital
1540 – 1640 hrs
Panel Discussion: ENABLE Healthcare
HEALTHCARE 4.0: Moving From Digital Health to ...Health
Farhana Nakhooda
General Manager & Senior Vice President
Health Catalyst
Arif Fahim
Regional Director - Asia Pacific, Health Economics & Reimbursement
Abbott
Shan Xu
Head, WHO Collaborating Centre for Digital Health
World Health Organization
Setiaji
Chief Digital Transformation Office & Expert Advisor of Health Technology to the Minister of Health
Ministry of Health, Indonesia
Young-Ae Jeong
Director General, Benefit Listing Department
Health Insurance Review and Assessment Service (HIRA), Korea
Dr. Sidharth Kachroo
Medical Director, Head, Medical Portfolio Management
Prudential Assurance Company Singapore
Anh Bourcet
Strategic Advisor
APACMed
Session Moderator
1700– 1750 hrs
Panel Discussion: ELEVATE The Industry
Be Digital-Future Ready: Unlocking Success for Industry in the Digital Era
Siddarth Satish
Global Vice President AI
Styker
Wai Chiong Loke
Head (Financing Redesign & mindline.sg)
Senior Consultant
MOHT
Dr. Rajendra Pratap Gupta
Founder
Health Parliament and Digital Health Academy (India)
Louise Agersnap
Head of the WHO Innovation Hub
World Health Organisation
Carla Cartwright
Head Global Digital and Regulatory Policy
Johnson & Johnson
Peter Liddell
Head of Life Sciences
KPMG Asia Pacific
Session Moderator
1750 – 1800 hrs
Closing Remarks
Birgitta Riani
Assistant Manager, Digital Health
APACMed
1530 – 1730 hrs
Room 324 (Level 3)
Legal, Ethics & Compliance Summit:
1530 – 1630 hrs
Presentation
Sustainable Solutions: ESG Compliance in MedTech
Chris Ahern
Partner-in-Charge, Sydney and Japan
Jones Day
Sushma Jobanputra
Partner-in-Charge, Singapore
Jones Day
1630 – 1730 hrs
Panel Discussion
Artificial intelligence in MedTech: Navigating Legal Horizons
Dean Ho
Provost's Chair Professor,
Director, The Institute for Digital Medicine
National University of Singapore
Lucas Nicolet-Serra
Counsel
K&L Gates Straits Law LLC
Raymond Chua
Deputy Director-General of Health (Health Regulation) Assistant Commissioner (Cybersecurity – Healthcare)
Ministry of Health, Singapore
Simon Chunkath
Vice President, IT Asia Pacific
Stryker
Chong Seow Wei
Regional Senior Editor
Tatler Gen. T
Session Moderator
Innovation Day (Hall 405, Level 4)
0900 – 0930 hrs
Registration, Networking & Innovation Exhibition Visit
0930 – 1000 hrs
Interactive Presentation
Opening Remarks and “MedTech Innovation Build vs Buy Landscape”
Opening Remarks
Begin Innovation Day by with an overview of the day’s agenda and expectations, insights from the APACMed Start-up Committee, and the significance of community engagement in fostering innovation.
MedTech Innovation Build vs Buy Landscape
Expect a deep dive into industry trends, enlightening case studies, and valuable insights in a comprehensive presentation on the MedTech innovation build-vs-buy landscape in the Asia Pacific. In addition, a snapshot of insights observed from the APACMed matchmaking database will be released.
Justin Leong
President, Asia & Latin America
ResMed
Stephen Sunderland
Head of SEA Healthcare & Life Sciences
LEK
Chris Hardesty
Strategic Advisor
APACMed
(Session Moderator)
1000 – 1045 hrs
Panel Discussion
Start-up-Corporate Matchmaking: Scaling Innovation Integration
Embark on an insightful journey with a Start-up founder sharing
the remarkable story of Gauss Surgical, a patient monitoring start-up and its evolution into a fully-integrated business unit of Stryker.
Following the presentation will be a fireside chat exploring the intricacies of the journey and provide valuable insights for start-ups looking to make that corporate pitch.
Siddarth Satish
Global Vice President AI
Stryker
Lynne Lim
Founder & CEO
NousQ
1045 – 1115 hrs
Mid-morning Networking Break
1115 – 1200 hrs
Panel Discussion
Realities of Matchmaking in the Asia Pacific, and Best Practices for Community Activation
Engage in a dynamic panel discussion that delves into the “Realities of Matchmaking in the Asia Pacific”. Our expert panelists will share insights, experiences, and best practices, providing a comprehensive exploration of the challenges and successes within the region’s matchmaking landscape. Discover key strategies for community activation and gain practical insights to enhance your approach in the diverse and dynamic Asia Pacific market.
Cecelia Zhou
VP, Strategy & BD, APAC
Stryker
Ajay Nair
President, APAC
TMG Search
Ren Jun Lim
Principal
Baker McKenzie Wong & Leow
Astra Lam
Head of New Business Development, China
Johnson & Johnson MedTech
Stephen Sunderland
Head of SEA Healthcare & Life Sciences
LEK
Session Moderator
1200 – 1330 hrs
Networking Lunch
1330 – 1600 hrs
Inaugural APACMed Corporate Challenge
Experience the convergence of ideas and solutions at the Inaugural APACMed Corporate Challenge Statement. Witness curated start-up matchmaking with 5-minute compelling pitches from each start-up, followed by Q&A session, dedicated time for fostering meaningful connections and collaboration within the MedTech ecosystem.
Biten Kathrani
Head of R&D, APJ region and Global Special Contact Lens Research, Vision
Johnson & Johnson MedTech
Jessie Qiu
General Manager and Head of Finance
ResMed
Dr. Hatim Abdulhussein
National Clinical Lead - AI and Digital Workforce, UK
NHS
Kenneth De Muynck
General Manager - Asia Pacific
Oliver Healthcare Packaging
Colin Tan
Investment Director
Coronet Ventures
Jacqueline Ng
Marketing Director - Asia / General Manager - ANZ
embecta
1600 – 1630 hrs
Reflections on Global MedTech Innovations and Closing Remarks
Chris Hardesty
Strategic Advisor
APACMed
Brian Benson
VP, Strategic Alliances
MedTech Innovator